echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > SCI Window "Nature" published the Chinese people to draw the endometrial cancer development and development cell map

    SCI Window "Nature" published the Chinese people to draw the endometrial cancer development and development cell map

    • Last Update: 2023-01-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com





    Recently, Chen Xiaojun of the Affiliated Obstetrics and Gynecology Hospital of Fudan University and Zhao Bing, State Key Laboratory of Genetic Engineering of Fudan University, published a paper in Nature Communications, which mapped the dynamic map of different cell subsets of cells during the transition from normal endometrial to endometrioid carcinoma through single-cell transcriptomic analysis, revealing the potential cell origin and pathological development process of endometrium-like carcinoma [1].


    Dr.
    Ren Xiaojun of the Obstetrics and Gynecology Hospital of Fudan University is the first author
    of this paper.
    Chen Xiaojun and Zhao Bing are co-corresponding authors of this article








    Research background








    Endometrial cancer is one of the most common gynecologic malignancies, and its incidence is on the rise worldwide
    .
    Endometrioid carcinoma is the most common type of endometrial cancer, and in-depth analysis of its pathogenesis is conducive to the development of accurate and effective new prevention and treatment strategies
    .
    The endometrium contains multiple types of cells such as epithelial, interstitial, and immunological, and multi-lineage cell differentiation and fate remodeling occur during the menstrual cycle, thereby maintaining endometrial physiological function and homeostasis
    .
    Although previous studies have depicted normal endometrial cell composition
    [2], the dynamics of cell subsets during the evolution of normal endometrium to endometrioid carcinoma are unclear
    .








    Research content








    The study revealed the characteristic changes
    of increased endometrial epithelial cells and decreased mesenchymal cells during the development of endometrioid carcinoma by single-cell transcriptomic sequencing analysis of normal endometrium, atypical hyperplasia endometrium, and endometrium-like carcinoma.
    Bioinformatics analysis further suggests that endometrioid carcinoma may have originated in epithelial cells rather than mesenchymal cells
    .
    Further subdivision of epithelial cell subsets found that nonciliary gland epithelial cells are a potential source of endometrioid carcinoma, and the available evidence does not support an evolutionary relationship
    between the stroma and epithelium.
    The study also found that LCN2+/SAA1/2+ epithelial cells are characteristic subsets during the development of endometrioid carcinoma, which appear in atypical hyperplasia foci and persist in endometrioid carcinoma, which is of great significance
    for the diagnosis of endometrial cancer.



    In addition, the study also depicts important features
    of the tumor microenvironment during the development of endometrial carcinoma.
    Among them, although the number of interstitial cell subsets did not change significantly, the endometrial epithelial organoid interstitial co-culture experiment showed that compared with normal mesenchymal cells, the ability of cancer mesenchymal cells to stimulate the expression of stem genes in the epithelium was significantly enhanced.
    Significant changes in the subset of immune cells during the occurrence of endometrial carcinoma are manifested as a decrease in the proportion of cytotoxic T cells and an increase in the proportion of regulatory T cells, suggesting that immune evasion may play an important role
    in the development of endometrial carcinoma.


    In summary, this study revealed the dynamic evolution of cell subsets during the evolution of normal endometrium to endometrioid carcinoma through single-cell transcriptomic sequencing, which provided new clues
    for the origin, early diagnosis and clinical treatment of endometrial cancer cells.


    References

    1.
    Ren, X.
     et al.
     Single-cell transcriptomic analysis highlights origin and pathological process of human endometrioid endometrial carcinoma.
     Nat Commun 13, 6300 (2022).

    2.
    Wang, W.
     et al.
     Single-cell transcriptomic atlas of the human endometrium during the menstrual cycle.
     Nat Med 26, 1644-1653 (2020).

    Author: Ren Xiaojun

    Editor/Typesetting: Wang Lu

    Review: Qiu Jia


    【Note】This article is a doctor's newspaper with the consent of the author to reprint the article, any institution or individual need to reprint, please contact the original author for authorization!



    The power to move the industry forward! The 8th Annual Meeting of Physicians 2023 is here!


    2023 "Doctor Daily" hot subscription!!! Millions of doctors are watching.
    .
    .





    "Physician Daily" submission public mailbox: yishibao2017@163.
    com

     

    【Note】Some pictures come from the Internet and WeChat moments, if there is infringement, please contact to delete, thank you! Phone: 010-58302828-6808

    At present, 1130000+ doctors have followed and joined us

           

           



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.